Mono Pharmacare Limited (NSE:MONOPHARMA)
India · Delayed Price · Currency is INR 8.95
0.00 (0.00%)
Sep 10, 2026, 3:19 PM IST
Mono Pharmacare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 3.53 | 30.9 | 24.42 | 9.44 | 3.51 |
Depreciation & Amortization | 1.14 | 1.29 | 1.15 | 0.51 | 1.08 |
Other Operating Activities | 32.85 | 40.08 | 31.37 | 13.05 | 8.66 |
Change in Accounts Receivable | -330.49 | -102.97 | -97.2 | -122.87 | -1.74 |
Change in Inventory | 129.61 | -130.94 | -96.06 | -265.95 | -5.73 |
Change in Accounts Payable | 104.22 | 91.13 | 29.26 | 0.08 | 20.91 |
Change in Other Net Operating Assets | 82.1 | 27.48 | 19.34 | -29.66 | -24.29 |
Operating Cash Flow | 22.97 | -43.03 | -87.72 | -395.4 | 2.4 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0.05 | -2.26 | -1.75 | -6.33 | -0.14 |
Investment in Securities | - | - | 5.73 | -5.88 | - |
Other Investing Activities | - | - | 0 | - | - |
Investing Cash Flow | -0.05 | -2.26 | 3.98 | -12.21 | -0.14 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | - | - | 195.94 | - |
Long-Term Debt Issued | 12.72 | 88.37 | - | 136.24 | 5.28 |
Total Debt Issued | 12.72 | 88.37 | - | 332.19 | 5.28 |
Short-Term Debt Repaid | - | - | - | - | -1.69 |
Long-Term Debt Repaid | - | - | -8.86 | - | - |
Total Debt Repaid | - | - | -8.86 | - | -1.69 |
Net Debt Issued (Repaid) | 12.72 | 88.37 | -8.86 | 332.19 | 3.59 |
Issuance of Common Stock | - | - | 122.87 | 84.44 | 2.29 |
Repurchase of Common Stock | - | - | - | -2.66 | - |
Other Financing Activities | -32.78 | -39.73 | -30.83 | -9.3 | -7.42 |
Financing Cash Flow | -20.06 | 48.64 | 83.18 | 404.67 | -1.54 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | 4.67 | -0 |
Net Cash Flow | 2.86 | 3.35 | -0.55 | 1.73 | 0.72 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 22.92 | -45.29 | -89.47 | -401.73 | 2.26 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | 1.38% | -2.69% | -7.31% | -121.21% | 0.61% |
Free Cash Flow Per Share | 1.30 | -2.56 | -5.83 | -70.92 | 0.46 |
Levered Free Cash Flow | -26.54 | -123.34 | -144.81 | -412.64 | -4.74 |
Unlevered Free Cash Flow | -5.81 | -101.14 | -127.02 | -407.35 | -0.65 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 33.18 | 35.53 | 28.47 | 8.45 | 6.55 |
Cash Income Tax Paid | 2.57 | 13.9 | 7.3 | - | 0.76 |
Change in Working Capital | -14.56 | -115.3 | -144.66 | -418.39 | -10.86 |